๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series

โœ Scribed by A. Sandhu; T. Alameel; C. H. Dale; M. Levstik; N. Chande

Book ID
114704611
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
111 KB
Volume
36
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Presentation and outcome of histoplasmos
Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series
โœ Jennifer L. Dotson; Wallace Crandall; Hayat Mousa; Jonathan R. Honegger; Lee Den ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB ๐Ÿ‘ 1 views

Background: Antitumor necrosis factor alpha (aTNF) therapies are commonly used in the treatment of pediatric inflammatory bowel disease (IBD). However, inhibition of the TNF-alpha pathway predisposes to serious infections, including histoplasmosis, which is the most common invasive fungal infection

Oral budesonide for the therapy of post-
Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: A case series and systematic review of the literature
โœ A. Sidney Barritt IV; Steven L. Zacks; Tara C. Rubinas; Hans H. Herfarth ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

## Background: The therapy for posttransplant ibd is clinically challenging. patients receiving liver transplants are immunosuppressed to prevent rejection, but via an unknown mechanism develop de novo ibd in spite of receiving some of the same medications used for therapy in traditional ibd. in th